Recent Advances in the Treatment Landscape for the Patient With BCG Unresponsive NMIBC
This interactive symposium will start by providing an introduction on how to identify a patient with bacillus Calmette-Guérin (BCG) unresponsive high-risk non-muscle invasive bladder cancer (NMBIC) followed by an overview of the current and emerging treatment options for this patient population. Finally, the experts will present a clinical case of a patient treated with BCG therapy who becomes unresponsive and will discuss the available treatment options and the clinical implications of the latest clinical data. Attendees will have the opportunity to submit questions to be addressed throughout the program.
Who Is the Patient With BCG Unresponsive NMIBC?,
Clinical Trial Updates for the BCG Unresponsive Patient,
The BCG Unresponsive Patient: A Patient Case
Shahrokh F. Shariat
Who Is the Patient With BCG Unresponsive NMIBC?, Clinical Trial Updates for the BCG Unresponsive Patient, The BCG Unresponsive Patient: A Patient Case
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Marek Babjuk, Ashish M. Kamat, Joan R. Palou